Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-03-01
2005-03-01
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S182000
Reexamination Certificate
active
06861426
ABSTRACT:
The present invention relates to lamotrigine, a useful agent for anti-epilepsia. New crystal forms of lamotrigine containing molecules of the solvent in stoichiometric ratios are disclosed. The present invention also provides processes for preparing the new crystal forms of lamotrigine.
REFERENCES:
patent: 4560687 (1985-12-01), Baxter et al.
patent: 6124308 (2000-09-01), Nobbs et al.
Janes et al., “Structure of Lamotrigine Methanol Solvate: 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine-Methanol, a Novel Anticonvulsant Drug,” Acta Cryst., 1989, C45, 129-132.
Pharmacopeial Forum, vol. 24, No. 1, (Jan.-Feb. 1998) p. 5438-5440.
E. Schmitt et al “Moisture-Dependent Crystallization of Amorphous Lamotrigine Mesylate” Journal of Pharmaceutical Sciences vol. 85, No. 11, Nov. 1996, pp. 1215-1219.
Aronhime Judith
Berkovich Yana
Dolitzky Ben-Zion
Garti Nissim
Gershon Neomi
Kenyon & Kenyon
Raymond Richard L.
Teva Pharmaceutical Industries Ltd.
LandOfFree
Crystal forms of lamotrigine and processes for their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystal forms of lamotrigine and processes for their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystal forms of lamotrigine and processes for their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3366976